Ensign Peak Advisors, Inc Iovance Biotherapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 74,592 shares of IOVA stock, worth $551,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,592

Previous 74,592 -0.0%

Holding current value

$551,980

Previous $598,000 17.06%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$7.78 - $14.19 $68,464 - $124,872	8,800 Added 13.38%	74,592 $598,000
Q1 2024 May 14, 2024	BUY	$7.59 - $17.47 $499,361 - $1.15 Million	65,792 New	65,792 $975,000
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $993,502 - $1.37 Million	104,250 Added 70.86%	251,371 $2.41 Million
Q2 2022 Aug 12, 2022	BUY	$6.38 - $18.33 $757,057 - $2.18 Million	118,661 Added 416.94%	147,121 $1.62 Million
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $2.79 Million - $4.3 Million	-225,020 Reduced 88.77%	28,460 $474,000
Q4 2021 Feb 11, 2022	BUY	$16.55 - $27.63 $987,472 - $1.65 Million	59,666 Added 30.79%	253,480 $4.84 Million
Q3 2021 Nov 12, 2021	BUY	$20.35 - $26.63 $3.19 Million - $4.18 Million	156,909 Added 425.17%	193,814 $4.78 Million
Q1 2021 May 12, 2021	SELL	$28.67 - $52.59 $41,858 - $76,781	-1,460 Reduced 3.81%	36,905 $1.17 Million
Q4 2020 Feb 12, 2021	SELL	$28.04 - $50.26 $17,104 - $30,658	-610 Reduced 1.57%	38,365 $1.78 Million
Q3 2020 Nov 12, 2020	BUY	$27.75 - $36.3 $320,679 - $419,482	11,556 Added 42.15%	38,975 $1.28 Million
Q1 2020 May 11, 2020	BUY	$19.54 - $38.85 $142,348 - $283,022	7,285 Added 36.18%	27,419 $821,000
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $361,405 - $592,140	20,134 New	20,134 $558,000

Others Institutions Holding IOVA

# of Institutions

312

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.17B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Iovance Biotherapeutics, Inc. Transaction History